ABIM IM BOARDS ITE STUDY GUIDE EXAM
PREP QUESTIONS AND ANSWERS 2026
◉ Iliotibial band syndrome
Answer: 1. Lateral knee pain,
2. Made worse by climbing down incline
3. Tenderness on palpation of lateral femoral condyle,
◉ example of central pain syndrome
Answer: fibromyalgia
◉ vaccine for asplenia
Answer: Should be given 14 days before surgery, or 2 weeks
preceding
1. Pneumococcal conjugate vaccine (PCV13) followed by
pneumococcal polysaccharide vaccine (PPSV 23) in 8 weeks
2. Hib once, if they have not received
3. Meningococcal conjugate vaccine (repeat after 8 weeks, then
every 5 years thereafter)
4. Meningococcal serogroup b [Menb)vaccine (repeat after 4 weeks)
,◉ Additional doses of Pneumococcal polysaccharide caccine
(PPSV23)
Answer: If age <65, 5 years after first dose, then again at age 65
(provided at least 5 years have passed since last administration)
◉ Management BPH
Answer: Mild symptoms- Observation first.
Moderate symptoms - Tamsulosin (alpha blocker)
Severe symptoms/Prostate volume >40ml - Finasteride (5 alpha
reductase inhibitor)
◉ Vestibular neuronitis
Answer: Acute, severe, persistent nonpositional peripheral vertigo
with no hearing loss.
Labyrinthitis is similar, however there is HEARING loss in
labyrinthitis.
Both may follow viral URTI
◉ first line therapy for upper airway cough syndrome in patients
with allergic rhinitis
, Answer: intranasal glucocorticoids
◉ type/class of laxative prescribed to patients on opioids
Answer: stimulant laxative (e.g senna, bisacodyl). if this does not
work, osmotic agents can be added (e.g miralax, lactulose).
◉ VTE prophylaxis in cancer patients who have undergone surgery
Answer: SC lovenox(enoxaparin) for up to 28 days after surgery
◉ prevention of progression strategy for dry age related macular
degeneration
Answer: high dose antioxidanttherapy
◉ prevention of progresssion strategy for wet age related macular
degeneration
Answer: vascular endotheliail growth factor inhibitor
◉ Tdap timing in pregnancy
Answer: every pregnancy, between 27 and 36 weeks
◉ Tuberculous meningitis additional therapy to 4-regimen
antituberculous therapy
PREP QUESTIONS AND ANSWERS 2026
◉ Iliotibial band syndrome
Answer: 1. Lateral knee pain,
2. Made worse by climbing down incline
3. Tenderness on palpation of lateral femoral condyle,
◉ example of central pain syndrome
Answer: fibromyalgia
◉ vaccine for asplenia
Answer: Should be given 14 days before surgery, or 2 weeks
preceding
1. Pneumococcal conjugate vaccine (PCV13) followed by
pneumococcal polysaccharide vaccine (PPSV 23) in 8 weeks
2. Hib once, if they have not received
3. Meningococcal conjugate vaccine (repeat after 8 weeks, then
every 5 years thereafter)
4. Meningococcal serogroup b [Menb)vaccine (repeat after 4 weeks)
,◉ Additional doses of Pneumococcal polysaccharide caccine
(PPSV23)
Answer: If age <65, 5 years after first dose, then again at age 65
(provided at least 5 years have passed since last administration)
◉ Management BPH
Answer: Mild symptoms- Observation first.
Moderate symptoms - Tamsulosin (alpha blocker)
Severe symptoms/Prostate volume >40ml - Finasteride (5 alpha
reductase inhibitor)
◉ Vestibular neuronitis
Answer: Acute, severe, persistent nonpositional peripheral vertigo
with no hearing loss.
Labyrinthitis is similar, however there is HEARING loss in
labyrinthitis.
Both may follow viral URTI
◉ first line therapy for upper airway cough syndrome in patients
with allergic rhinitis
, Answer: intranasal glucocorticoids
◉ type/class of laxative prescribed to patients on opioids
Answer: stimulant laxative (e.g senna, bisacodyl). if this does not
work, osmotic agents can be added (e.g miralax, lactulose).
◉ VTE prophylaxis in cancer patients who have undergone surgery
Answer: SC lovenox(enoxaparin) for up to 28 days after surgery
◉ prevention of progression strategy for dry age related macular
degeneration
Answer: high dose antioxidanttherapy
◉ prevention of progresssion strategy for wet age related macular
degeneration
Answer: vascular endotheliail growth factor inhibitor
◉ Tdap timing in pregnancy
Answer: every pregnancy, between 27 and 36 weeks
◉ Tuberculous meningitis additional therapy to 4-regimen
antituberculous therapy
